Back to programme
Mon 20 Oct 25 14:30-16:00
SCS
Future vaccination strategies - PART 1 SCS03
Auditorium 1 - Plenary Hall
Chairs
Florian KRAMMER
ESWI Board Member, Medical University of Vienna, Austria
Read more
Marios KOUTSAKOS
University of Melbourne, Australia
Read more
Ended Now live Upcoming
  1. A Dendritic Cell-targeting Approach to Deliver a Universal Influenza Vaccine Candidate to the Respiratory Mucosa
    Daryl LEENational University of Singapore, Singapore
  2. Development of a next-generation COVID-19 intranasal vaccine based on a multivalent NDV-HXP-S formulation.
    To be confirmed
  3. Superior protection and prevention of transmission upon influenza infection by adjuvanted mucosal vaccination in the guinea pig influenza model.
    To be confirmed
  4. Broad betacoronavirus immunity and SARS-CoV-2 protection induced by divergent spike-based nucleoside-modified vaccines
    To be confirmed
  5. The Additive Effect of Neuraminidase Inclusion in Influenza Vaccine Formulations using a Self-Amplifying RNA Platform
    Giuseppe PALLADINOCSL, United States
  6. Evaluation of a broadly protective influenza B virus vaccine based on mosaic hemagglutinin platforms in mice.
    To be confirmed